title: How Regenerative Medicine Stakeholders Adapt to Ever-Changing Technology and Regulatory Challenges? Snapshots from the World TERMIS Industry Symposium (September 10, 2015, Boston).
abstract: Regenerative medicine (RM) is a fascinating area of research and innovation. The huge potential of the field has been fairly underexploited so far. Both TERMIS-AM and TERMIS-EU Industry Committees are committed to mentoring and training young entrepreneurs for more successful commercial translation of upstream research. With this objective in mind, the two entities jointly organized an industry symposium during the past TERMIS World Congress (Boston, September 8-11, 2015) and invited senior managers of the RM industry for lectures and panel discussions. One of the two sessions of the symposium-How to overcome obstacles encountered when bringing products to the commercial phase?-aimed to share the inside, real experiences of leaders from TEI Biosciences (an Integra Company), Vericel (formerly Aastrom; acquirer of Genzyme Regenerative Medicine assets), RegenMedTX (formerly Tengion), Mindset Rx, ViThera Pharmaceuticals, and L'Oreal Research & Innovation. The symposium provided practical recommendations for RM product development, for remaining critical and objective when reviewing progress, for keeping solutions simple, and for remaining relevant and persistent.
authors: 1 Medtronic-Sofradim Production , Trévoux, France .
authors: Yves
authors: Y
authors: Bayon
authors: 2 Virginia Tech , Blacksburg, Virginia.
authors: Mark
authors: M
authors: Van Dyke
authors: 3 TEI Biosciences , Boston, Massachusetts.
authors: Robert
authors: R
authors: Buelher
authors: 4 Vericel , Ann Arbor, Michigan.
authors: Ross
authors: R
authors: Tubo
authors: 5 RegenMEdTx , Winston-Salem, North Carolina.
authors: Tim
authors: T
authors: Bertram
authors: 6 MindSet Rx & ViThera Pharmaceuticals , Arlington, Texas.
authors: Bernard
authors: B
authors: Malfroy-Camine
authors: 7 L'Oreal Research & Innovation , Paris, France .
authors: Michelle
authors: M
authors: Rathman
authors: 8 UNT System College of Pharmacy , Fort Worth, Texas.
authors: Vincent
authors: V
authors: Ronfard
mesh_terms: D015316:Genetic Therapy / Q000331:legislation & jurisprudence; D006801:Humans; D018973:Intellectual Property; D044968:Regenerative Medicine / Q000331:legislation & jurisprudence* / Q000379:methods*; D012926:Social Control, Formal; D023822:Tissue Engineering / Q000331:legislation & jurisprudence
keywords: business management; commercial translation; recommendations; regenerative medicine; tissue engineering